• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

MetaModix

Is Medtronic’s spine business headed to the auction block? | Wall Street Beat

February 21, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

The message to Medtronic’s (NYSE:MDT) spine business from chairman and CEO Omar Ishrak was clear today: Shape up or ship out.

During a conference call with analysts to discuss the med-tech titan’s fiscal 3rd-quarter results, Ishrak said he was “not happy” that the division posted a 9% revenue decline and warned that the spine unit must raise its game or face the consequences.

Filed Under: Funding Roundup, MassDevice Earnings Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Abiomed, AirStrip Technologies, Avedro Inc., Clearside Biomedical, Core Oncology, Deals Roundup, Group Purchasing Organizations (GPO), HCA, HealthTrust Purchasing Group, integer, Leerink Partners, MetaModix, NeuroNexus, Olympus, Palomar Medical Technologies Inc., Personnel Moves, Premier Inc., Q4, Teleflex, Theragenics Corp.

Stealthy MetaModix looks for new approach to diabetes, bariatric surgery

February 18, 2011 By MedCity News Leave a Comment

A stealthy Minnesota medical device company is moving ahead with plans to develop a minimally invasive approach to bariatric surgery and better solve the problem of Type II diabetes.

MetaModix is one-third of the way through a $1.9 million angel round, according to a federal regulatory filing and company executives. It is using the money to develop its product and perform some preclinical testing. MetaModix hopes to be in European clinical trials by early next year, said Kedar Belhe, the company’s chief executive officer.

Filed Under: News Well Tagged With: Angel Investment, Bariatrics, MetaModix

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS